selegiline has been researched along with Experimental Mammary Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Meites, J; Quadri, SK; Thyagarajan, S | 1 |
| Felten, DL; Felten, SY; ThyagaRajan, S | 1 |
| Quadri, SK; ThyagaRajan, S | 1 |
| Felten, DL; Madden, KS; Stevens, SY; ThyagaRajan, S | 1 |
4 other study(ies) available for selegiline and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Deprenyl reinitiates estrous cycles, reduces serum prolactin, and decreases the incidence of mammary and pituitary tumors in old acyclic rats.
Topics: Aging; Animals; Body Weight; Estrus; Female; Mammary Neoplasms, Experimental; Menopause; Organ Size; Pituitary Neoplasms; Prolactin; Rats; Rats, Sprague-Dawley; Selegiline | 1995 |
Antitumor effect of L-deprenyl in rats with carcinogen-induced mammary tumors.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Body Weight; Chromatography, High Pressure Liquid; Dopamine; Female; Hypothalamus, Middle; Injections, Intraperitoneal; Mammary Neoplasms, Experimental; Neuroprotective Agents; Norepinephrine; Rats; Rats, Sprague-Dawley; Selegiline; Serotonin; Time Factors | 1998 |
L-deprenyl inhibits tumor growth, reduces serum prolactin, and suppresses brain monoamine metabolism in rats with carcinogen-induced mammary tumors.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Monoamines; Body Weight; Brain; Dopamine; Eating; Female; Homovanillic Acid; Hydroxyindoleacetic Acid; Mammary Neoplasms, Experimental; Monoamine Oxidase Inhibitors; Norepinephrine; Prolactin; Rats; Rats, Sprague-Dawley; Selegiline | 1999 |
Anti-tumor effect of L-deprenyl is associated with enhanced central and peripheral neurotransmission and immune reactivity in rats with carcinogen-induced mammary tumors.
Topics: 3,4-Dihydroxyphenylacetic Acid; 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Cell Division; Female; Flow Cytometry; Hydroxyindoleacetic Acid; Immune System; Interferon-gamma; Interleukin-2; Killer Cells, Natural; Mammary Neoplasms, Experimental; Monoamine Oxidase Inhibitors; Neuroimmunomodulation; Norepinephrine; Rats; Rats, Sprague-Dawley; Selegiline; Serotonin; Spleen; Sympathetic Nervous System; Synaptic Transmission; T-Lymphocytes | 2000 |